Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice

2005 ◽  
Vol 23 (7) ◽  
pp. 1383-1389 ◽  
Author(s):  
Jun Suzuki ◽  
Masaru Iwai ◽  
Zhen Li ◽  
Jian-Mei Li ◽  
Li-Juan Min ◽  
...  
Keyword(s):  
Calcium Antagonist ◽  
Apolipoprotein E ◽  
At1 Receptor ◽  
Receptor Blocker ◽  
At1 Receptor Blocker ◽  
Deficient Mice

Effects of adjuvant-induced arthritis on the ventral prostate of rats treated with angiotensin AT1 receptor blocker

Life Sciences ◽  
2020 ◽  
Vol 252 ◽  
pp. 117629
Author(s):  
Emerson Souza da Rocha ◽  
Fabiana de Campos Gomes ◽  
Murilo Romano de Oliveira ◽  
Ricardo Vinicius Bruneto ◽  
Rodrigo Miranda Ramos Borges ◽  
...  
Keyword(s):  
At1 Receptor ◽  
Receptor Blocker ◽  
Ventral Prostate ◽  
At1 Receptor Blocker ◽  
Adjuvant Induced Arthritis

AT1 receptor blocker azilsartan medoxomil normalizes plasma miR-146a and miR-342-3p in a murine heart failure model

Biomarkers ◽  
2016 ◽  
Vol 22 (3-4) ◽  
pp. 253-260 ◽  
Author(s):  
Manami Kaneko ◽  
Tomoko Satomi ◽  
Shuji Fujiwara ◽  
Hidefumi Uchiyama ◽  
Keiji Kusumoto ◽  
...  
Keyword(s):  
Heart Failure ◽  
At1 Receptor ◽  
Receptor Blocker ◽  
Failure Model ◽  
At1 Receptor Blocker ◽  
Heart Failure Model ◽  
Azilsartan Medoxomil

scholarly journals 1014 Regression of atherosclerosis in apolipoprotein-E deficient mice is feasible using high-dose angiotensin receptor blocker

2012 ◽  
Vol 30 ◽  
pp. e294
Author(s):  
Kaori Hayashi ◽  
Hiroyuki Sasamura ◽  
Tatsuhiko Azegami ◽  
Hideyo Oguchi ◽  
Mari Nakamura ◽  
...  
Keyword(s):  
Apolipoprotein E ◽  
Angiotensin Receptor Blocker ◽  
Receptor Blocker ◽  
High Dose ◽  
Angiotensin Receptor ◽  
Deficient Mice
Sign in / Sign up

Export Citation Format

Share Document